Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

UNIPEN

NAFCILLIN SODIUM

Standard Dose
EQ 250MG BASE
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview UNIPEN is listed in Drugs@FDA under application 050111 (NDA).

Marketing status: Discontinued Active ingredient NAFCILLIN SODIUM Form and strength CAPSULE;ORAL - EQ 250MG BASE Sponsor WYETH AYERST Submission history Latest submission status date: 1996-07-30 00:00:00.

Structured Monograph

Clinical summary

Approval overview UNIPEN is listed in Drugs@FDA under application 050111 (NDA). Marketing status: Discontinued Active ingredient NAFCILLIN SODIUM Form and strength CAPSULE;ORAL - EQ 250MG BASE Sponsor WYETH AYERST Submission history Latest submission status date: 1996-07-30 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.
UNIPEN (NAFCILLIN SODIUM) | Drug Monograph | MedicHelpline